MedTrace Logo

A Novel Computer-Based Therapy for Social Anxiety

NCT03240003 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-02-04

No results posted yet for this study

Summary

The present study is a double blind trial that seeks to examine the feasibility, acceptability, efficacy, and mechanism of a recently developed eye-tracking-based therapy (GC-MRT) in individuals with social anxiety disorder (SAD)

Conditions

Interventions

BEHAVIORAL

GC-MRT

Group 1 will receive a 4-week (8-sessions) course of GC-MRT

BEHAVIORAL

modified GC-MRT

group 3 will receive a 4-week (8-sessions) course of GC-MRT, modified

BEHAVIORAL

Non-GC-MRT

Group 2 will receive a 4-week (8-sessions) course of non-GC-MRT

Sponsors & Collaborators

  • New York State Psychiatric Institute

    lead OTHER

Principal Investigators

  • Franklin Schneier, MD · NYSPI

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-25
Primary Completion
2026-12-01
Completion
2026-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03240003 on ClinicalTrials.gov